Astria Therapeutics Stock Investor Sentiment

ATXS Stock  USD 14.08  0.48  3.53%   
Slightly above 66 percent of all Astria Therapeutics' private investors are curious in acquiring. The analysis of the overall investor sentiment regarding Astria Therapeutics suggests that a large number of traders are confidant. Astria Therapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in Astria Therapeutics. The current market sentiment, together with Astria Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Astria Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Astria Therapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Astria daily returns and investor perception about the current price of Astria Therapeutics as well as its diversification or hedging effects on your existing portfolios.
  

Astria Therapeutics Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Astria Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Astria Therapeutics Maximum Pain Price across 2024-04-19 Option Contracts

Astria Therapeutics' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Astria Therapeutics close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Astria Therapeutics' options.
2 days ago at simplywall.st         
Astria Therapeutics, Inc.s institutional investors lost 19 percent last week but have benefitted fro...
Simply Wall St News at Macroaxis
3 days ago at investing.com         
Oppenheimer stay bullish on Astria Therapeutics shares, lifts PT to 29
Investing News at Macroaxis
few days ago at businesswire.com         
Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b...
businesswire News
few days ago at finance.yahoo.com         
Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b...
Yahoo News
few days ago at investing.com         
Astria reports promising STAR-0215 trial results for HAE treatment
Investing News at Macroaxis
few days ago at businesswire.com         
Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b...
businesswire News
few days ago at finance.yahoo.com         
Astria Therapeutics, Inc. is favoured by institutional owners who hold 53 percent of the company
Yahoo News
over a week ago at news.google.com         
Astria Therapeutics Stock Price Down 6.9 percent - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
Astria Therapeutics Trading 3.8 percent Higher - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
Astria Therapeutics Rating Reiterated by HC Wainwright - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
Astria Therapeutics Reaches New 52-Week High at 15.87 - Defense World
Google News at Macroaxis
over a week ago at news.google.com         
Astria Therapeutics, Inc. Sees Large Drop in Short Interest - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
Astria Therapeutics Share Price Passes Above 50-Day Moving Average of 12.01 - MarketBeat
Google News at Macroaxis
over two weeks ago at zacks.com         
Is Artivion Stock Outpacing Its Medical Peers This Year?
zacks News
over two weeks ago at thelincolnianonline.com         
Astria Therapeutics Earns Outperform Rating from Wedbush
news
Far too much social signal, news, headlines, and media speculation about Astria Therapeutics that are available to investors today. That information is available publicly through Astria media outlets and privately through word of mouth or via Astria internal channels. However, regardless of the origin, that massive amount of Astria data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Astria Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Astria Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Astria Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Astria Therapeutics alpha.

Astria Therapeutics Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
Astria Therapeutics Secures Funds for RD Through Stock Sale - TipRanks.com - TipRanks
02/01/2024
2
Acquisition by Jill Milne of 534600 shares of Astria Therapeutics subject to Rule 16b-3
02/12/2024
3
Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma Immunology Annual Meeting
02/20/2024
4
How to Take Advantage of moves in - Stock Traders Daily.com
02/26/2024
5
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635
03/05/2024
6
HC Wainwright Comments on Astria Therapeutics, Inc.s Q1 2024 Earnings - Defense World
03/08/2024
7
Astria Therapeutics Share Price Passes Above 50-Day Moving Average of 12.01 - MarketBeat
03/15/2024
8
Astria Therapeutics Rating Reiterated by HC Wainwright - MarketBeat
03/18/2024
9
Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b2 Trial of STAR-0215 for HAE
03/25/2024
10
Astria Therapeutics, Inc.s institutional investors lost 19 percent last week but have benefitted from longer-term gains
03/27/2024
When determining whether Astria Therapeutics is a strong investment it is important to analyze Astria Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Astria Therapeutics' future performance. For an informed investment choice regarding Astria Stock, refer to the following important reports:
Check out Astria Therapeutics Hype Analysis, Astria Therapeutics Correlation and Astria Therapeutics Performance.
For more information on how to buy Astria Stock please use our How to Invest in Astria Therapeutics guide.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Complementary Tools for Astria Stock analysis

When running Astria Therapeutics' price analysis, check to measure Astria Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astria Therapeutics is operating at the current time. Most of Astria Therapeutics' value examination focuses on studying past and present price action to predict the probability of Astria Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astria Therapeutics' price. Additionally, you may evaluate how the addition of Astria Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Global Correlations
Find global opportunities by holding instruments from different markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Is Astria Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astria Therapeutics. If investors know Astria will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astria Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.42)
Return On Assets
(0.17)
Return On Equity
(0.31)
The market value of Astria Therapeutics is measured differently than its book value, which is the value of Astria that is recorded on the company's balance sheet. Investors also form their own opinion of Astria Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Astria Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astria Therapeutics' market value can be influenced by many factors that don't directly affect Astria Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Astria Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Astria Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astria Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.